Treatment of Scabies
First-Line Treatment for Classic Scabies
Permethrin 5% cream is the preferred first-line treatment for classic scabies, applied to all areas of the body from the neck down and washed off after 8-14 hours, with one application generally curative. 1, 2, 3
Application Guidelines by Age Group
- Adults and children ≥10 years: Apply permethrin from the neck down only, avoiding the scalp unless immunocompromised 2, 4
- Infants, young children <2 years, elderly, and immunocompromised patients: Apply permethrin to the entire body including scalp, hairline, neck, temple, and forehead, as these populations commonly have scalp involvement 1, 4, 3
- Approximately 30 grams is sufficient for an average adult 3
Oral Ivermectin as Alternative First-Line
Oral ivermectin 200 μg/kg body weight, repeated in 2 weeks, is an equally effective first-line alternative to permethrin. 1, 2, 5
- Must be taken with food to increase bioavailability and epidermal penetration 1, 5, 4
- The second dose at 2 weeks is essential because ivermectin has limited ovicidal activity and does not kill eggs present at initial treatment 1, 2
- Contraindicated in children weighing <15 kg or younger than 10 years due to potential blood-brain barrier penetration and neurotoxicity 4
- No dosage adjustments required for renal impairment, though safety of multiple doses in severe liver disease is unknown 1
Special Populations
Pregnant and Lactating Women
Permethrin 5% cream is the preferred treatment for pregnant or lactating women. 1, 2, 4
- Ivermectin is classified as "human data suggest low risk" in pregnancy but lacks sufficient safety data 2, 4
- Lindane is absolutely contraindicated due to association with neural tube defects and accumulation in placenta and breast milk 1
Infants and Young Children
Permethrin is the recommended treatment for infants and young children, including those <2 months old. 4, 3
- Lindane should never be used in children <10 years due to high risk of seizures and neurotoxicity 1, 2, 4
- Ivermectin is contraindicated in children weighing <15 kg 4
Immunocompromised Patients
Immunocompromised patients require closer monitoring and are at higher risk for crusted scabies and treatment failure. 2, 5
- These patients should receive scalp-to-toes application of permethrin regardless of age 2
Crusted (Norwegian) Scabies Management
Crusted scabies requires aggressive combination therapy: 5% permethrin cream applied daily for 7 days then twice weekly until cure, plus oral ivermectin 200 μg/kg on days 1,2,8,9, and 15. 1, 2, 5
- Additional ivermectin doses on days 22 and 29 may be required for severe cases 1
- Single-dose topical scabicide or oral ivermectin alone will fail in crusted scabies due to massive mite burden 1, 5
- Crusted scabies occurs in immunodeficient, debilitated, or malnourished persons and is far more contagious than typical scabies 1, 5
- Lindane must be avoided in this population due to risk of neurotoxicity with heavy applications or denuded skin 1, 5
- Specialist consultation is recommended for crusted scabies management 4
Alternative Treatment Options (When First-Line Fails or Unavailable)
Recent evidence suggests declining permethrin efficacy in some regions, making alternatives increasingly relevant:
- Benzyl benzoate 25%: 87% cure rate but causes burning sensation in 43% of patients 2, 6
- Sulfur 6% ointment: Applied nightly for 3 consecutive nights, washing off previous applications before reapplying 2
- Crotamiton 10% cream: Applied nightly for 2 consecutive nights, washed off 24 hours after second application 2
- Lindane 1%: Only if patient cannot tolerate recommended therapies or these have failed; applied thinly from neck down and washed off after 8 hours 1, 2
Lindane Contraindications and Precautions
Lindane should not be used in children <10 years, pregnant/lactating women, persons with extensive dermatitis, or immediately after bathing. 1, 2, 4
- Seizures have occurred when lindane was applied after a bath or used by patients with extensive dermatitis 1
- Aplastic anemia and resistance have been reported 1
Contact and Environmental Management
All persons with sexual, close personal, or household contact within the preceding month must be examined and treated simultaneously, even if asymptomatic. 2, 5, 4
- Bedding and clothing should be machine-washed and machine-dried using hot cycle, dry-cleaned, or removed from body contact for at least 72 hours 1, 2, 4
- Fumigation of living areas is unnecessary 1, 2, 4
- Keep fingernails closely trimmed to reduce injury from scratching 1, 2
- For institutional outbreaks, treat the entire at-risk population concurrently, preferably with mass oral ivermectin for ease of administration 4
Follow-Up and Retreatment Criteria
Pruritus and rash may persist for up to 2 weeks after successful treatment due to allergic dermatitis, not treatment failure. 1, 2, 5
- Persistent pruritus alone is not an indication for retreatment 2
- Retreatment is indicated only after 2 weeks if live mites are observed, symptoms persist beyond 2 weeks, or new lesions continue to appear 2, 5, 4
- Use an alternative regimen if retreatment is necessary 4
Common Reasons for Treatment Failure
- Resistance to medication or faulty application of topical scabicides 1, 5
- Reinfection from untreated contacts or fomites 2, 5
- Failure to treat all close contacts simultaneously 2, 5
- Not repeating ivermectin dose after 2 weeks 2, 5
- Using lindane after bathing or in contraindicated populations 2, 5
Critical Treatment Pitfalls to Avoid
- Do not apply topical corticosteroids during active treatment, as this can suppress inflammatory response and allow mites to proliferate 5
- Do not skip the second ivermectin dose at 2 weeks 2, 5
- Do not use single-application permethrin for crusted scabies—this will fail 5
- Do not expect immediate symptom resolution—allow up to 2 weeks for post-treatment pruritus to resolve 2, 5
- Do not use lindane in children <10 years, pregnant women, after bathing, or in extensive dermatitis 1, 2, 4
Emerging Resistance Concerns
A 2024 double-blinded randomized controlled trial demonstrated only 27% cure rate with permethrin versus 87% with benzyl benzoate, suggesting reduced sensitivity of scabies mites to permethrin in some populations 6. This finding, while concerning, does not yet warrant changing first-line recommendations based on current CDC and FDA guidelines, but clinicians should maintain low threshold for switching to alternative agents if treatment fails 1, 2, 3.